Loading clinical trials...
Loading clinical trials...
Safety and Efficacy to Reduce the IOP of the Fixed Association of Latanoprost 0.005% (50 μg/mL)/ Brinzolamide 1% (10mg/mL) Drops, Compared to Latanoprost 0.005% (50 μg/mL) Drops, in Patients With Open Angle Glaucoma or Ocular Hypertension
Conditions
Interventions
Latanoprost+Brinzolamide combination
Latanoprost
Locations
1
Brazil
Department of Ophthalmology / Hospital São Paulo
São Paulo, São Paulo, Brazil
Start Date
December 1, 2012
Primary Completion Date
March 1, 2013
Completion Date
June 1, 2013
Last Updated
December 11, 2014
NCT07396441
NCT07390890
NCT05902871
NCT07218796
NCT07119580
NCT06865144
Lead Sponsor
Adapt Produtos Oftalmológicos Ltda.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions